The Coronary Plaque Reimbursement Playbook: Inside Elucid's $55M Raise and the Economics of Non-Invasive Cardiovascular AI
Dr. Dereck Mush, MD, MBA
Anumana
Develops AI enabled electrocardiogram algorithms to detect hidden cardiac conditions.
What they do
Designs AI driven algorithms that analyze standard 12 lead ECGs to detect complex, often asymptomatic cardiac conditions such as low ejection fraction and pulmonary hypertension. Its technology is designed for integration into clinical software used by physicians.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Electrocardiogram analysis AI
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- Cambridge, United States
- Region
- North America
- Founded
- 2021
- Total funding
- $25M raised
Notable investors: Mayo Clinic, nference.
Also in Cardiovascular
Related on The Signal
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
At-home semen analysis is turning a taboo test into a routine one
At-home semen analysis is turning a taboo test into a routine one
Dr. Dereck Mush, MD, MBA
Who Is Liable When AI Clinical Decision Support Gives Bad Advice?
Dr. Dereck Mush, MD, MBA
When Medical Devices Start a Conversation: Inside Penn’s Epilepsy Study
Dr. Dereck Mush, MD, MBA